Skip to main content

Table 1 Clinicopathological characteristics of patients with pancreatic ductal adenocarcinoma stratified by CLCA1 expression

From: Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma

Factors Low CLCA1
N = 87
High CLCA1
N = 53
P value Missing
Age, years 69 (62–75) 68 (64–72) 0.258  
Female gender 44 (50.6) 29 (54.7) 0.634  
T-stage    0.649 0.7%
 - T1 12 (13.8) 7 (13.2)   
 - T2 58 (66.7) 35 (66.0)   
 - T3 16 (18.4) 10 (18.9)   
 - T4 0 1 (1.9)   
N-stage    0.485 1.4%
 - N0 21 (24.1) 12 (22.6)   
 - N1 30 (34.5) 24 (45.3)   
 - N2 34 (39.1) 17 (32.1)   
AJCC stage, 8th edition    0.835 1.4%
 - IA 4 (4.6) 2 (3.8)   
 - IB 12 (13.8) 7 (13.2)   
 - IIA 4 (4.6) 3 (5.7)   
 - IIB 31 (35.6) 23 (43.4)   
 - III 34 (39.1) 18 (34.0)   
Tumor differentiation    0.879 1.4%
 - Well 4 (4.6) 3 (5.7)   
 - Moderate 28 (32.2) 20 (37.7)   
 - Poor 50 (57.5) 29 (54.7)   
 - Undifferentiated 3 (3.4) 1 (1.9)   
R1 resection margin 35 (40.2) 20 (37.7) 0.552 0.7%
Adjuvant chemotherapy 68 (78.2) 45 (84.9) 0.129 3.6%
  1. Qualitative data are expressed as N (%) and quantitative data as median (interquartile range). AJCC American joint committee on cancer